Switch to:
Novo Nordisk A/S (NYSE:NVO)
Cash Flow for Capital Expenditures
$-649 Mil (TTM As of Jun. 2014)

Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Novo Nordisk A/S's cash flow for capital expenditures for the three months ended in Jun. 2014 was $-161 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Jun. 2014 was $-649 Mil.


Definition

Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Novo Nordisk A/S Cash Flow for Capital Expenditures for the trailing twelve months (TTM) ended in Jun. 2014 was -183.315038419 (Sep. 2013 ) + -156.050374156 (Dec. 2013 ) + -148.168701443 (Mar. 2014 ) + -161.343012704 (Jun. 2014 ) = $-649 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Novo Nordisk A/S Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
Cash Flow_CPEX -557-633-578-480-363-587-698-578-646-665

Novo Nordisk A/S Quarterly Data

Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14
Cash Flow_CPEX -99-145-181-204-157-156-183-156-148-161
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK